Business Wire

Imperva Data Security Fabric Provides Bold New Approach to Securing All Data in Multicloud and Hybrid Environments

5.4.2022 15:00:00 EEST | Business Wire | Press release

Share

Imperva, Inc., (@Imperva) the comprehensive digital security leader, introduces the Imperva Data Security Fabric (DSF) to modernize and simplify data governance, security, and workflow management for all data across multicloud and hybrid environments. Imperva DSF standardizes data security controls across enterprise environments to provide full visibility of what is happening across all file stores and assets, on-premises, and across clouds. Its flexible architecture supports a wide range of data repositories, ensuring security policies are applied consistently everywhere.

Imperva DSF integrates Imperva Sonar and a deep portfolio of industry-leading and mission critical Imperva Data Security products and technologies. Customers are already using Imperva DSF capabilities to secure data in hundreds of data stores across leading cloud providers. These capabilities provide access to thousands of automation and response integrations to streamline visibility, create specific rules for managing data risk, and leverage a mix of security tools supporting those platforms.

Imperva DSF makes it easier for customers to understand and mitigate data risk at every step of their security journey across structured, semi-structured, and unstructured data. According to Gartner, “by 2024, larger enterprises will triple the unstructured data stored as file or object storage on-premises, at the edge or in the public cloud, compared with 2020. This massive growth in unstructured data demands better protection against threats such as ransomware.1” Imperva DSF can discover and classify more than 350 unique file formats, including the most widely used formats by Adobe, Google, Microsoft, and many others. Imperva DSF protects a customer’s multicloud and hybrid environments and provides visibility through a single service that can run anywhere within that environment. Imperva DSF provides a holistic view that makes it easier for customers to quickly identify and secure sensitive information across their entire protected environment.

Across a broad range of areas including policy compliance, compromised credentials, unintentional misuse, and malicious threats to sensitive data, organizations in all industries around the world are asking for our help to protect their data. They need broad but centralized control and automation for a more comprehensive view of risk posture, faster insights to accelerate response times, and reduced cost of ownership,” says Dan Neault, SVP and GM, Data Security, Imperva. “Imperva Data Security Fabric enables organizations to safeguard their sensitive data while ensuring data security, compliance, and privacy, and managing digital risk while confidently moving strategic data to the cloud.”

Imperva DSF and its unique automation capabilities for agent and agentless deployments makes it simpler and lower cost for customers to scale data governance and protection anywhere. "After going through a painful situation with another Data Activity Monitoring solution, we went with Imperva because we needed to deliver something quickly for compliance reasons. Imperva offered us a more efficient agent-based solution in terms of cost, management and a lot less complexity. You get to do everything in a single place,” says Diego Laverde, CISO of Banco Popular Dominicano. “It went into production seamlessly, the business didn’t even realize that it had happened, and it worked as it should.”

Through the Imperva Technology Alliance Program (TAP), Imperva DSF has built-in integrations with the world’s leading hyperscalers (e.g., Amazon Web Services, Microsoft® Azure®, Google Cloud™, etc.), database vendors (e.g., Microsoft®, MongoDB® Atlas, Oracle DBMS, Snowflake, etc.), and workflow managers (e.g., Atlassian, ServiceNow, etc.). Imperva DSF opens up new partner-builder innovation opportunities to provide customers additional capabilities and simplify their orchestration. Imperva TAP is pleased to welcome Mage™ (formerly Mentis), a data masking alternative to Imperva DSF built-in capabilities to help customers secure structured and unstructured data throughout the development lifecycle.

“We are excited about the possibilities Imperva DSF enables for mutual customers and the partner ecosystem,” says Rajesh Parthasarathy, CEO of Mage. “Our technology alliance with Imperva provides organizations with an analyst-recognized integrated masking solution for all data types supported by the Imperva DSF.”

Imperva Data Security Fabric includes:

  • Data Activity Monitoring: mitigate malicious insiders and external threats by detecting changes, auditing activities for compliance, and blocking or alerting on policy violations.
  • Data Risk Analytics: automate detection of non-compliant, risky, or malicious data access behavior across data stores.
  • Data Governance: discover and classify sensitive data residing in structured, semi-structured, and unstructured data types, to operationalize security control policies.
  • Data Access Control: control user rights to sensitive data, including detecting overly-broad data access in the cloud or on-premises.
  • Data Masking: transform data so it is either unreadable or de-identified, allowing processing to happen in compliance.

Additional Information:

GARTNER is registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved

About Imperva

Imperva is the comprehensive digital security leader on a mission to help organizations protect their data and all paths to it. Only Imperva protects all digital experiences, from business logic to APIs, microservices, and the data layer, and from vulnerable, legacy environments to cloud-first organizations. Customers around the world trust Imperva to protect their applications, data, and websites from cyber attacks. With an integrated approach combining edge, application security, and data security, Imperva protects companies ranging from cloud-native start-ups to global multi-nationals with hybrid infrastructure. Imperva Threat Research and our global intelligence community keep Imperva ahead of the threat landscape and seamlessly integrate the latest security, privacy, and compliance expertise into our solutions.

© 2022 Imperva, Inc. All rights reserved. Imperva is a registered trademark of Imperva, Inc.

1Gartner Hype Cycle for Storage and Data Protection Technologies, Julie Palmer, 22 July 2021

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Erik Kingham
erik.kingham@imperva.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu

The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’30.4.2026 23:42:00 EEST | Press release

The Empire State Building (ESB), the “World’s Most Famous Building,” will celebrate its 95th anniversary on May 1, 2026, with new offers at the Empire State Building Observation Deck, a special birthday tower lighting display, and a slate of celebrations to honor its legacy and future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430693323/en/ The Empire State Building Celebrates 95 Years as the ‘World’s Most Famous Building’ “The Empire State Building celebrates its 95th anniversary, still the ‘World’s Most Famous Building,’ a modernized, sustainability leader as technologically advanced today as the day she was completed, and the winner of #1 Top Attraction in the United States in Tripadvisor’s Travelers’ Choice Awards for 2026,” said Anthony E. Malkin, chairman and CEO of Empire State Realty Trust. Anniversary Offerings and Experiences To mark its 95th anniversary, the Empire State Building will debut new experiences

MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis30.4.2026 23:17:00 EEST | Press release

MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that MH002, the Company’s lead rationally designed Live Biotherapeutic Product (LBP) candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate ulcerative colitis (UC). MH002 today is the most advanced LBP targeting inflammatory bowel disease (IBD)-specific mechanisms and is composed of a rationally designed microbial consortium of six well-characterized commensal strains. The FDA’s Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important drugs to patients earlier. Fast Track designation enables frequent communication with the FDA to discuss the drug's development plan and ensure collection o

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye